Accessibility Tools
Clinical trial offers hope to restore limb function in man with complete cervical spinal cord injury

Physicians at Rush University Medical Center became the first in Illinois to inject AST-OPC1 (oligodendrocyte progenitor cells), an experimental treatment, into the damaged cervical spine of a recently paralyzed man as part of a multicenter clinical trial.

Read more

Source: Medical Xpress